Display options
Cite
Rovira J. 'The pros and cons of a single euro-price for drugs' and 'the economics of parallel trade'. Pharmacoeconomics. 1998;14(1):135-7doi: 10.2165/00019053-199814010-00010.
Rovira, J. (1998). 'The pros and cons of a single euro-price for drugs' and 'the economics of parallel trade'. PharmacoEconomics, 14(1), 135-7. https://doi.org/10.2165/00019053-199814010-00010
Rovira, J. "'The pros and cons of a single euro-price for drugs' and 'the economics of parallel trade'." PharmacoEconomics vol. 14,1 (1998): 135-7. doi: https://doi.org/10.2165/00019053-199814010-00010
Rovira J. 'The pros and cons of a single euro-price for drugs' and 'the economics of parallel trade'. Pharmacoeconomics. 1998 Jul;14(1):135-7. doi: 10.2165/00019053-199814010-00010. PMID: 10182191.
Copy Download .nbib Format: NLM
Share it on

Pharmacoeconomics. 1998 Jul;14(1):135-7. doi: 10.2165/00019053-199814010-00010.

'The pros and cons of a single euro-price for drugs' and 'the economics of parallel trade'.

PharmacoEconomics

J Rovira

PMID: 10182191 DOI: 10.2165/00019053-199814010-00010

[No abstract available.]

References

  1. Health Policy. 1997 Jun;40(3):199-215 - PubMed
  2. Pharmacoeconomics. 1998 Mar;13(3):271-6 - PubMed
  3. Pharmacoeconomics. 1998 Mar;13(3):293-304 - PubMed

MeSH terms

Publication Types

LinkOut - more resources